ABSTRACT-The aim of the present study was to visualize the superficial glomeruli of the Munich-Wistar (MW) rat and to characterize the responses of the renal microvasculature to endothelin-1 (ET-1). We first ex amined the distribution of superficial glomeruli of the MW rat compared to that in a control strain (Wistar rat). Secondly, we examined the effects of ET-1 on the renal microcirculation of the MW rat. The right kidney was perfused with a Krebs-Ringer solution containing fluorescein isothiocyanate dextran (FITC-dex tran) and was visualized under an epi-illuminated fluorescence microscope system. Changes in perfusion pressure and diameter of the microvessels accompanying the administration of ET-1 (10 fmole-300 pmole) were measured. The number of superficial glomeruli was greater in the MW rat than in the Wistar rat. ET-1 had long-lasting and dose-dependent pressor effects. Perfusion pressure showed a 3.5-fold increase com pared with the control, and the afferent arterioles showed greater dose-dependent vasoconstriction than the efferent arterioles. These findings suggest that the MW rat is a useful animal model for the study of renal microcirculation and that the renal microcirculation is extremely sensitive to ET-1.
The homeostatic regulation of the hemodynamics and the metabolic functions of the kidney is mediated by mul tiple control mechanisms. It has recently been suggested that endothelin-1 (ET-1), a potent long-lasting vasocon strictor, may play an essential role in the regulation of blood flow in the arteries and veins of almost all organs (1) (2) (3) (4) (5) . For example, the inappropriate release of ET-1 could conceivably contribute to the pathogenesis of a vast number of cardiovascular diseases, including systemic hypertension, vascular spasm, myocardial ischemia and congestive heart failure (4). Some studies have demon strated that ET-1 stimulated the generation of inositol triphosphate (IP3) in vascular smooth muscles, which then mobilized calcium ions from intracellular stores (6) . However, the mechanisms by which endothelin mediates vascular tonus in the cardiovascular system have not yet been completely elucidated.
In the kidney, ET-1 has been shown to produce marked and sustained reductions in both renal blood flow and glomerular filtration rate (7) . Therefore, it is suggest ed that ET-1 may be an important factor in the pathogene sis of hemodynamically-mediated renal failure. In fact, high affinity binding sites for ET-1 have recently been identified both in the glomeruli and in the inner medulla (8) (9) (10) . Autoradiographic studies in the rat kidney have also revealed the localization of ET-1 binding in various blood vessels and tissues such as the renal artery and vein, glomerulus, arcuate artery, interlobular artery, vascular bundle and renal papilla (11) . Nevertheless, the direct ac tions of ET-1 on the renal microcirculation have not yet been determined in detail, and evidence that ET-1 is produced within the renal microvasculature is currently lacking. To shed some light on this area, the effects of endothelins on renal microcirculation should be investi gated under direct intravital microscopic observation, if a proper animal model is available.
The glomerulus is generally surrounded by convolu tions of the proximal tubules, and thus is not directly ac cessible from the surface. In the Munich strain of Wistar rats (Munich-Wistar; MW), however, some glomeruli are located near the surface of the kidney (12, 13) . This unique characteristic of MW rat kidney has permitted the direct measurement of hydrostatic pressure in glomerular capillaries and Bowman's spaces, and the evaluation of various factors that may determine the glomerular filtra tion rate (14) . Such characteristics of the MW rat have particular advantages over those of other species in visualizing the renal microcirculation by intravital microscopy. Furthermore, since some intrarenal mecha nisms that indirectly affect renal hemodynamics are lack ing in isolated perfused kidney preparations, an in vivo model may allow the additional effects of ET-1 to be inves tigated by microscopy.
The present study was performed to visualize the micro circulation in the superficial glomeruli using the isolated perfused MW rat kidney and to directly characterize the actions of ET-1 on the afferent and efferent arterioles. Our findings indicate that ET-1 is a potent renal vasocon strictor that exerts its vasoconstrictive effects predomi nantly in the arterioles, and in particular in the afferent arterioles.
MATERIALS AND METHODS
All experiments were conducted according to the Guide for the Care and Use of Laboratory Animals established by the University of Tsukuba, and these guidelines are in agreement with those of the US National Institutes of Health (NIH Publication No. 85-23, revised 1985) .
Two series of experiments, i.e., morphological studies for observing the distribution of glomeruli and the intra vital microscopic observation of renal microcirculation, were performed.
Morphological studies
In this series of experiments, the distribution of super ficial glomeruli in the kidney of the MW rat (Charles River Laboratories, Atsugi) was compared with that in a con trol (Wistar) strain (Charles River Laboratories). Male MW rats (n = 5) and Wistar rats (n = 5) of the same age (7 8 weeks), weighing 200 230 g, were sacrificed by an intravenous overdose of pentobarbital sodium, and the right kidneys were immediately removed. The kidneys were fixed in 10% formaldehyde, cut into 10-pm-thick sec tions and stained with hematoxylin-eosin.
The numbers of glomeruli in the MW and Wistar rats were counted on light photomicrographs.
Each photo micrograph was divided into 5 area zones of the same width (200 pm), parallel to the renal surface. For each zone, the total number of glomeruli was counted manual ly for both strains. Measurements were repeated three times on the same photomicrograph, and the measured values were averaged.
Intravital observation of the renal microcirculation
The MW rats (n=10) were anesthetized with intra peritoneal injection of pentobarbital sodium (50 mg/kg), and sodium heparin (200 units/kg) was injected via the femoral vein for anticoagulation. The kidney was then exteriorized, and microscopic ob servation of the renal microcirculation was carried out while the perfusate was constantly circulated. In these ex periments, the right kidneys were chosen for the perfu sion experiments, because the superior mesenteric artery branches were at the same level as the right renal artery, and, consequently, a cannula to perfuse the kidney could be passed from side to side without causing blood loss and without interrupting the blood flow to the kidney dur ing preparation (15) . After laparotomy, loose ligatures were placed around the right renal and the superior mesen teric arteries. The right renal artery was then cannulated by introducing a polyethylene cannula (3-french) for the injection of ET-1 and for monitoring the perfusion pres sure through the superior mesenteric artery. The right kid ney was perfused with Krebs-Ringer solution by means of a roller pump (Masterflex PA-21; Cole-Parmer Instru ment Co., Chicago, IL, USA) at a constant flow rate of 2 2.5 ml/min during the experiments. The vena cava was dissected, and the kidney was quickly removed, after which the surrounding connective tissue was then re moved.
The composition of the perfusate was: 113 mM NaCl, 4.8 mM KC1, 2.2 mM CaC12, 1.2 mM MgSO4i 25 mM NaHCO3, 5.5 mM, containing 5.5 mM glucose and 0.8 mg/ml bovine serum albumin (Fraction V; Sigma Chemi cal Co., St. Louis, MO, USA). The medium was main tained at 37C and was aerated with 95076 02-5076 C02 Its pH was adjusted to approximately 7.4.
The microcirculatory perfusate blood flow in the isolat ed perfused kidney was then observed by an intravital tele vision microscope system. The arrangement of the intravi tal microscope system and the perfusion circuit is shown schematically in Fig. 1 . This system and the microvascu lar visualization technique were essentially the same as those that we used previously to visualize the myocardial microcirculation (16) . In short, to obtain a clear visualiza tion of the perfused flow in the microvessels, fluorescein isothiocyanate (FITC)-labeled dextran (FITC-dextran 150S, MW 150,000; Sigma Chemical Co.) was dissolved in the perfusate (1 mg/ml), and its fluorescence was visual ized with a CCD video camera (model VC-D300; Sanyo Electric Co., Ltd., Osaka) under an epi-illuminated fluorescence microscope system (model VANOX; Olym pus Optical Co., Ltd., Tokyo). Video images from the CCD camera were recorded with a video cassette recorder (model AG-2860; Matsushita Electric Industry Co., Ltd., Osaka). The observed microvessels were identified as arterioles or venules by observing the direction of movement of un stained red blood cells added to the perfusate solution (1 ml/ 150 ml). This perfusion technique enabled clear visualization of the perfused flow in the microvascu lature, particularly in the afferent and efferent arterioles. Perfusion pressure was measured with a pressure trans ducer (Model MPU-0.5A; Nihon Kohden, Tokyo) through the cannula placed in the renal artery, and record ed on a polygraph system (RM-6000, Nihon Kohden).
Endothelin-1 (Peptide Institute, Osaka) was dissolved and stored in a 0.05% albumin solution to avoid deactiva tion. After ET-1 administration, changes in the afferent and efferent arteriolar diameters were measured in each experiment. The kidneys were allowed to equilibrate for at least 15 min before control measurements were taken. After control data were obtained, ET-1 (10 fmole-300 pmole) was administered cumulatively through a cannula placed in the perfusion circuit, and perfusion pressure and the vessel diameter were measured at 1 min after each administration of ET-1.
After each experiment, the microvascular diameter was measured directly on a printed photomicrograph of the replayed still video images of the microvasculature using a video printer (model UP-850; Sony Co., Ltd., Tokyo). Measurements of the vessel diameter were repeated three times in 5 points from the glomerulus to a distance of 30 im on the same photograph, and the measured values were averaged.
Statistical analyses
All data are expressed as means ±S.E.M. The contrac tile responses of the arterioles are expressed as percent decrease in diameter. Data were analyzed by one-way analysis of variance (ANOVA). If ANOVA indicated a sig nificant difference, dose-dependent changes in contractile response within experimental groups were subjected to Fisher's analysis; differences between the two groups were assessed by the two-tailed unpaired Student's t-test (17) . Probability values of P<0.05 were considered statistical ly significant. Figure 2 shows a photomicrograph of a superficial glomerulus in the MW rat kidney. The photomicrographs allowed us to quantify the density of the glomeruli within an arbitrarily selected region of interest by directly count ing the number of glomeruli. In this particular example, the diameter of the superficial glomerulus was estimated to be 120 pm. Our preliminary observations showed that MW rats at the age of 7 8 weeks had higher densities of superficial glomeruli than those at an age of 9-10 weeks. Figure 3 shows the density of glomeruli thus estimated for each zone in the MW rats (solid columns) and the Wistar rats (open columns). These morphological studies showed a greater density of superficial glomeruli in the MW rats. Comparison of the densities of the glomeruli showed a significant difference between the kidneys of the Intravital observation of the renal microcirculation The isolated perfused kidneys of MW (n=5) and Wistar rats (n=5) were observed by intravital microscopy. Figure 4 , taken from still playback images, shows a typical image of an efferent arteriole (diameter, 18 um) under the fluorescent microscope. The afferent and/or efferent arterioles within the glomerulus were iden tified by observing the direction of movement of un stained red blood cells added to the perfusate solution. Figure 5 , in which dose-response curves for the increase in perfusion pressure following cumulative application of ET-1 are plotted, shows the pressor effects of ET-1 on the microvessels of the isolated MW rat kidney. ET-1 showed a long-lasting and dose-dependent pressor effect. The mean perfusion pressure increased significantly from 61 ±3 mmHg at a dose of 300 fmole of ET-1 to 216 ± 15 mmHg at 100 pmole; i.e., a 4.3-fold increase compared with the control values (50± 1 mmHg). Such pressor effects of ET-1 showed significant differences from the control at doses of more than 300 fmole (P < 0.05).
RESULTS

Morphological studies
The vasoactive effects of ET-1 were easily quantified from the fluorescently visualized images of the micro vasculature. Figure 6 shows the vasoconstrictive effects of ET-1 on the afferent and efferent arterioles of the MW rat. The mean diameter of the arterioles observed under the control conditions was 21.3 ± 1.2 tm (n=5) and 19.8 ± 1.4 im (n = 5) for the afferent and efferent arteri oles, respectively. The afferent arterioles showed dose-de pendent vasoconstriction after ET-1 administration, the degree of constriction of these vessels being much greater than in the efferent arterioles. The percent constriction of afferent arterioles was significantly different from that of the efferent arterioles at ET-1 doses of more than 30 fmole (P<0.05). Moreover, the contractile response of the afferent arterioles to ET-1 occurred evenly along the entire length of the vessel and showed a significant differ ence at doses of more than 30 fmole compared with the control. At higher doses of ET-1 (3 10 pmole), the blood flow in the afferent arterioles was markedly reduced. However, the contractile response of the efferent arteri oles to ET-1 were not significantly different from the con trol values. In these experiments, unusual phenomena such as backward flow, stasis or shunt flow between the afferent and efferent arterioles were frequently observed. These findings seemed to provide evidence of drastic microcirculatory disturbance due to administration of exogeneous ET-1. 
DISCUSSION
Endothelin-1 (ET-1), a peptide produced by vascular endothelial cells, is now recognized as the most potent mammalian vasoconstrictor peptide thus far described (1, 4, 18) . Although the action of ET-1 as a paracrine or cir culating mediator is not yet well understood, there is con siderable evidence that endothelins play a substantial role in the regulation of cardiovascular and renal function, and there are clear indications of diseases in which they may be implicated (4) .
Since, as yet, little is known about the mechanisms by which ET-1 controls the vascular tonus of the kidney, the role played by ET-1 in physiological and pathophysiologi cal states in this organ is difficult to determine at present. With respect to the hemodynamic effects of ET-1 on the renal circulation, Harris et al. (19) reported that renal hemodynamic and tubular transport responses to low dose infusions of ET-1 (1 and 10 ng/kg/min) in anesthe tized rats were reduced towards their predicted physiologi cal level, and the actions of ET-1 were predominantly depressor, vasodilator and natriuresis. Stacy et al. (20) examined the direct effects of continuous intrarenal infusions of ET-1 without inducing systemic effects and confirmed that ET-1 had profound direct actions in reduc ing renal hemodynamics and electrolyte excretion. These previous studies showed that the changes in renal hemodynamics and tubular transport functions induced by ET-1 occurred at lower plasma levels than those in ducing any systemic change. Furthermore, Kon et al. (21) , who used anti-ET antibodies in an ischemic kidney model intending to deactivate endogenous ET, suggested that this peptide was involved in the onset of acute renal ischemic injury. Plasma levels of ET-1 have been shown to be elevated in patients undergoing hemodialysis treat ment and in patients with acute or chronic renal failure (4, (22) (23) (24) . Thus, although these studies show that ET-1 plays an important role in renal function and disease, we still have little information derived from the direct obser vation of physiological and pathophysiological states related to ET-1 in the kidney.
In the kidney, the afferent and efferent arterioles are the major sites exhibiting vascular resistance, and therefore their behavior is the most important determinant of renal blood flow and the glomerular filtration rate. Recent studies have addressed the effects of ET-1 on renal micro circulation. Badr et al. (7) reported that micropuncture pressure measurements with MW rats showed a marked increase in the afferent and efferent arteriolar resistance accompanying the intravenous administration of ET-1. Using a single isolated perfused arteriole from rabbit kid ney, Edwards et al. (25) also reported that ET-1 induced potent vasoconstriction of both the afferent and efferent arterioles. In micropuncture studies using MW rats given continuous intravenous infusions of ET-1 (0.63 pmol/min), King et al. (26) reported that ET-1 caused a proportionately greater elevation of the vascular resistance of efferent rather than afferent arterioles, and they also found that a marked elevation of glomerular capillary hydraulic pressure and a lower glomerular capil lary ultrafiltration coefficient were induced by ET-1. These indirect observations suggested that the renal vas cular effects of ET-1 were localized to the afferent or the efferent arterioles.
Recent studies utilizing video microscopic observation of the microvascular blood flow in Wistar rats, as used in the present study, have shown that ET-1 reduced the diameter of these vessels. For example, Loutzenhiser et al. (27) reported that, in the isolated perfused hydronephrotic kidney, ET-1 was a po tent vasoconstrictor of the afferent arterioles with a threshold vasoconstriction response at a dose of 0.01 nM, whereas it had a lesser effect in reducing the efferent arteriolar diameter. Fretschner et al. (28) used a split hydronephrotic rat kidney model and found that in travenous ET-1 (100 ng/kg/min) induced elevated sys temic blood pressure, decreased glomerular blood flow and preferentially constricted larger preglomerular vessels such as the arcuate artery. However, to our knowledge, no direct demonstration of the involvement of the affer ent or efferent arterioles in normal kidneys has been made to date; the studies cited above were carried out in special ized kidneys, such as the hydronephrotic kidney. Similar ly to previous reports (29) , our present study of the isolat ed perfused MW rat kidney showed that the direct microvascular action of ET-1 was predominant in the afferent arterioles, the efferent arterioles being less affect ed. Moreover, our results showed a significant increase in perfusion pressure at concentrations from 300 fmole, and significant contraction of the arterioles from 30 fmole. Although we could not completely explain this discrep ancy, it may be a result of differences in total renal vascu lar resistance and the sensitivity of afferent arterioles to ET-1.
The MW rat kidney was confirmed to be a valuable model for assessing the microvascular hemodynamic ac tion of ET-1 in that glomeruli could be directly observed. The advantage of using this strain is that most glomeruli are located under the vicinal surface of the kidney, and with this glomerular localization, the glomerular vessels and fluid from the Bowman's capsule are directly acces sible (12, 13) . Therefore, extensive pharmacological and physiological studies of glomerular characteristics have been carried out with this strain (30) (31) (32) (33) (34) (35) (36) . With respect to the localization of glomeruli, Hackbarth et al. (12) report ed that an average of 3-4 superficial glomeruli was ob served in each histological section in MW rats aged be tween 20 and 100 days, while in the control rat kidney, only 2 superficial glomeruli were found in all histological sections. They also reported that at ages of over 100 days, the number of superficial glomeruli diminished to about one per section. In the present study, we obtained similar results, in that the MW rats at ages of 7 8 weeks had a higher density of superficial glomeruli than those at 9-10 weeks of age. Therefore, we used the MW rats at 7 8 weeks age to observe the superficial glomeruli.
Although a few investigators have attempted to deter mine the effects of ET-1 on renal hemodynamics by micropuncture studies of the MW rat kidney, they were unable to determine the site of action of ET-1 in the renal microvasculature (7, 26, 36, 37) . Thus, since a very limit ed number of studies have reported the effects of ET-1 in MW rat kidneys, we attempted in the present study to characterize the renal hemodynamic effects of ET-1 direct ly, in terms of morphological findings in the MW rat kid ney. Moreover, since isolated perfused kidney models are free from systemic hemodynamic effects and metabolism by nonrenal tissues as well as the effects of accumulation of ET-1 in the perfusate, the present model enables the study of the effects of ET-1 per se. In the present study, under direct intravital microscopic observation, we demonstrated, for the first time, that the action of ET-1 was primarily characterized by a response of afferent ar terioles. These findings also supported the soundness of the use of the isolated perfused MW rat kidney in pharma cological and physiological studies of the renal micro circulation.
In this study, we used a fluorescently labeled tracer solu tion of high molecular weight (FITC-dextran, MW 150,000) to visualize or map the renal microvasculature. The use of this tracer was justified by the report of Stein hausen et al. (38) , who injected the tracer intravenously. They reported that the tubular passage of dextran was not marked and that no tubular passage was found even after increased amounts of dextran were injected. Pallone et al.
(39) also reported in a micropuncture study using the MW rat that a buffer solution containing FITC-dextran (MW 2,000,000, 5 mg/ml) and albumin (MW 60,000, 0.1 g/dl) exerted only negligible intracapillary oncotic pressure (1.4 mmHg). Our preliminary study also showed that high molecular weight FITC-dextran (MW 150,000) did not alter renal hemodynamics. Therefore, we concluded that the present visualization technique was suited for ex periments.
In conclusion, ET-1 alone was confirmed to be a potent vasoconstrictor with preferential activity in the renal microvasculature.
The results of the present study pro vided evidence of the direct action of ET-1 on renal resistance vessels. Furthermore, the primary site of vasoconstriction induced by ET-1 was shown to be local ized to the afferent arterioles. Under the present ex perimental conditions, no effects of ET-1 were observed in the efferent arterioles. Finally, the MW rat was confirmed to be a useful animal model for studying renal microcirculation.
